Trending...
- Governor Gavin Newsom signs SB 27, strengthening California's CARE Act and expanding access to behavioral health services
- Mullins McLeod Surges Into SC Governor's Race with $1.4 Million Raised in First Quarter; Most from His Own Commitment, Not Political Pockets
- Richline Transportation Expands Luxury Airport Transfer and Black Car Service in San Diego
MOUNTAIN VIEW, Calif. - Californer -- Adaptic Health, a leading provider of clinical development software, today announced the launch of its new platform designed to streamline the clinical trial design process. Clinical trials are essential for advancing medical research and bringing new treatments to patients, but they can be complex and time-consuming and the existing tools available for clinical study protocol development have not kept up with the increasing complexity. With the advent of new challenges such as remote approaches, genetic advancements, and diverse patient populations, the need for a more efficient and effective approach to trial design has become increasingly pressing.
Adaptic Health's platform provides biopharma companies with a digital infrastructure for clinical development, starting with trial design. The platform empowers Chief Medical Officers (CMOs) and clinical teams with collaboration tools, a dynamic literature review, and what-if analysis capabilities, reducing the time and cost of clinical trial design by up to six months and saving millions of dollars.
"We are thrilled to bring this innovative solution to the market, especially in the wake of the COVID-19 pandemic, which has highlighted the need for accelerated trial design and execution across any disease area," said Luke Stewart and co-founder, CEO of Adaptic Health. "Our platform streamlines collaboration and enables users to learn from the past, explore different design tradeoffs, and accelerate protocol approval, all in one convenient and powerful platform."
More on The Californer
Adaptic Health's platform leverages previous experience to help CMOs and clinical teams improve the chances of success in their clinical trials. The platform consolidates historic FDA decisions and real-world data, providing a comprehensive resource for understanding the regulatory landscape and making informed decisions about trial design. Additionally, the platform's simulation tools allow users to explore different design tradeoffs and scenarios, such as the impact of different sample sizes or endpoint definitions, and see how they might affect the outcomes of the trial.
"The ability to simulate design tradeoffs is crucial for CMOs and other decision-makers who need to make informed choices about the direction and focus of their clinical trial development program," said Charles Barr, Chief Medical Officer and co-founder of Adaptic Health. "Our platform provides a powerful and convenient way to access and analyze data, making it easier for users to make informed decisions and optimize their trial design."
"Clinical trial design is a creative process. As such, inspiration is key. Adaptic Health brings the past into view so you can create the best future for your development program," said Stanley Lewis, CEO of A28 Therapeutics. "You also get faster stakeholder buy-in of your plan through the collaborative trial summary. By bringing this element into focus early, Adaptic accelerates the journey to clinical trial success."
More on The Californer
Visit us on our website at https://www.adaptichealth.io or email us at sales@adaptichealth.io to learn how you can get early access to the platform, now available in beta. The platform is expected to be generally available in 6 months.
About Adaptic Health
Adaptic Health offers a powerful software as a service (SaaS) platform that helps organizations accelerate clinical development from the earliest stage of design through biostatistical optimization. Our platform streamlines collaboration, enables dynamic literature review, and provides what-if analysis tools, reducing the time and cost of clinical trial design by up to six months and saving millions of dollars.
Adaptic Health's platform provides biopharma companies with a digital infrastructure for clinical development, starting with trial design. The platform empowers Chief Medical Officers (CMOs) and clinical teams with collaboration tools, a dynamic literature review, and what-if analysis capabilities, reducing the time and cost of clinical trial design by up to six months and saving millions of dollars.
"We are thrilled to bring this innovative solution to the market, especially in the wake of the COVID-19 pandemic, which has highlighted the need for accelerated trial design and execution across any disease area," said Luke Stewart and co-founder, CEO of Adaptic Health. "Our platform streamlines collaboration and enables users to learn from the past, explore different design tradeoffs, and accelerate protocol approval, all in one convenient and powerful platform."
More on The Californer
- LSC Destruction Launches Cutting-Edge Cryptocurrency Scanning to Hard Drive Destruction Services
- California highlights earthquake preparedness for Great ShakeOut Day
- DALPS Announces Global Airdrop to Reward Users and Expand Its Offers Marketplace
- Governor Newsom expands response arsenal with new emergency services facility in Southern California
- ALYXX Features on Oceans In Silhouette "Under My Skin" Single
Adaptic Health's platform leverages previous experience to help CMOs and clinical teams improve the chances of success in their clinical trials. The platform consolidates historic FDA decisions and real-world data, providing a comprehensive resource for understanding the regulatory landscape and making informed decisions about trial design. Additionally, the platform's simulation tools allow users to explore different design tradeoffs and scenarios, such as the impact of different sample sizes or endpoint definitions, and see how they might affect the outcomes of the trial.
"The ability to simulate design tradeoffs is crucial for CMOs and other decision-makers who need to make informed choices about the direction and focus of their clinical trial development program," said Charles Barr, Chief Medical Officer and co-founder of Adaptic Health. "Our platform provides a powerful and convenient way to access and analyze data, making it easier for users to make informed decisions and optimize their trial design."
"Clinical trial design is a creative process. As such, inspiration is key. Adaptic Health brings the past into view so you can create the best future for your development program," said Stanley Lewis, CEO of A28 Therapeutics. "You also get faster stakeholder buy-in of your plan through the collaborative trial summary. By bringing this element into focus early, Adaptic accelerates the journey to clinical trial success."
More on The Californer
- $150 Million Financing Initiates N A S D A Q's First Tether Gold Treasury Combining the Stability of Physical Gold with Blockchain $AURE
- DALPS Launches Marketplace Allowing Businesses to Trade Offers Like Stocks
- California: Governor Newsom announces affordable CalRx® insulin, $11 a pen, will soon be available for purchase
- Cardirun Foldable Treadmill for Home and Office, 10% Incline, 320 LBS Weight Capacity
- Podcast for Midlife Women Entrepreneurs Celebrates 100th Episode with Rhea Lana's Founder and CEO
Visit us on our website at https://www.adaptichealth.io or email us at sales@adaptichealth.io to learn how you can get early access to the platform, now available in beta. The platform is expected to be generally available in 6 months.
About Adaptic Health
Adaptic Health offers a powerful software as a service (SaaS) platform that helps organizations accelerate clinical development from the earliest stage of design through biostatistical optimization. Our platform streamlines collaboration, enables dynamic literature review, and provides what-if analysis tools, reducing the time and cost of clinical trial design by up to six months and saving millions of dollars.
Source: Adaptic Health
Filed Under: Health
0 Comments
Latest on The Californer
- The Mogharebi Group Facilitates $34.6 Million Sale of Willow Grove Apartments in Modesto, CA
- UK Website Launches "Toy Time Machine" — Find Your Childhood Christmas Toy in One Click
- Rachel Farris, CPA Named Among Forbes' Top CPAs in America
- California: Crime is down in San Francisco, key law enforcement partnerships yield successful results
- Scott St. Germain, U.S. Army Veteran and Vice President at Genentech, Joins Dream Foundation Board
- New West Symphony: E.T. The Extra-Terrestrial in Concert
- Vesper Public Relations is selected as an official supplier of the LASEC Business Connect Program
- California announces coalition of Governors forming new alliance to protect public health from political interference
- $73.6M Pipeline, $10M Crypto Play & Legal Firepower: Why Investors Are Watching Cycurion (N A S D A Q: CYCU) Like a Hawk
- Grammy award-winning Cuban-Canadian artist Alex Cuba releases his 11th studio album, "Indole"
- Thread Advisory Group Launches to Help Retailers Turn Strategy Into Lasting Results
- QView Medical and Eve Wellness Announce Partnership to Advance Direct-to-Consumer Breast Cancer Screening With FDA-Approved AI
- New Article Reveals Common Pricing Pitfalls in Flooring Projects — And How to Avoid Them
- Inside the Practice of a Caring Dentist Bringing Personalized Care to La Jolla
- Airbus Defence and Space and Omnitronics Sign MoU to Advance Interoperability in Critical Communications
- City of Long Beach Confirms First Case of Clade I Mpox
- DERMA-CODE™ Introduces the World's First Synergistic Skincare Combining NAD+, PDRN, and Peptides
- Memory and Return – Debut Concert Featuring David Hidalgo and Members of Quetzal
- California protects over 40K acres of agricultural land, supporting rural communities
- Ship Overseas Inc Reports 37% Revenue Growth as EV Shipping to Africa Accelerates